Skip to content

Clinical and economic implications of stepping down inhaled corticosteroids in patients with chronic stable asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12335748
Enrollment
250
Registered
2004-01-23
Start date
1999-01-02
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory tract diseases: Asthma Respiratory Asthma

Interventions

Step down inhaled steroid over one year

Sponsors

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult asthmatic patients

Exclusion criteria

Exclusion criteria: 1. Chronic Obstructive Pulmonary Disease (COPD) 2. Low dose inhaled steroids

Design outcomes

Primary

MeasureTime frame
Exacerbation rate

Secondary

MeasureTime frame
Inhaled steroid dose

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026